Shares of Applied DNA Sciences (NASDAQ:APDN) fell 7.8% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share rose 36.11% year over year to ($0.46), which missed the estimate of ($0.22).
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.22) by 109.09 percent. This is a 36.11 percent increase over losses of $(0.72) per
Gainers
Windtree Therapeutics, Inc. (NASDAQ: WINT) shares rose 55.8% to $2.82 in pre-market trading after dropping over 10% on Friday. The company recently reported a wider loss for its second quarter.
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.